Clinical Trial

Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 5, 2026 (before its estimated June 29, 2026 completion). Its status may not reflect the trial's current state.
Summary
This research is to determine if an oral probiotic, Pendulum Glucose Control (PGC), can be safely given to patients during pelvic radiation therapy (RT). The researchers will study if the probiotics lessen gastrointestinal toxicity during pelvic radiation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-14.
Status change: Not Yet Recruiting → Recruiting 2026-02-02
Trial Details
NCT Number NCT07231588
Lead Sponsor University of Cincinnati
Collaborators: Pendulum Therapeutics
Conditions Radiation Injuries
Enrollment 20 participants
Start Date 2026-01-29
Primary Completion 2026-06-29 (estimated)
Study Completion 2026-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-02-05